Maxim Group Downgrades IntelliPharmaCeutics International (IPCI) to Hold
Tweet Send to a Friend
Maxim Group downgraded IntelliPharmaCeutics International (NASDAQ: IPCI) from Buy to Hold with a price target of $3.00 (from $7.00).Analyst Jason ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
